Document is current
Any future updates will be listed below
-
Authors
Slob, Bart P. H. https://orcid.org/0009-0008-9125-0190
Postma, Maarten J. https://orcid.org/0000-0002-6306-3653
Weersma, Maaike
Rocca, Hans-Peter Brunner-La https://orcid.org/0000-0002-4356-8566
de Jong, Lisa A. https://orcid.org/0000-0001-8814-0670
Boersma, Cornelis https://orcid.org/0000-0002-1190-2638
-
Funding
Funding for this research was provided by:
Boehringer Ingelheim
- License Information
-
More Information
Article History
Accepted: 29 June 2025
First Online: 12 July 2025
Declarations
:
: This study was funded by Boehringer Ingelheim Netherlands.
: Cornelis Boersma and Maarten Postma receive grants and honoraria from various pharmaceutical companies, including Boehringer Ingelheim. They are both shareholders of Health-Ecore, the Netherlands, which received a consultancy fee for the conduct of this study. Bart Slob and Lisa de Jong are employees at Health-Ecore. Maaike Weersma is an employee at Boehringer Ingelheim Netherlands, the funder of this study. Hans-Peter Brunner-La Rocca has received consultancy fees from Boehringer-Ingelheim, unrelated to this publication. The authors meet criteria for authorship as recommended by the International Committee of Medical Journal Editors (ICMJE). The authors did not receive payment related to the development of this manuscript. Boehringer Ingelheim was given the opportunity to review the manuscript for medical and scientific accuracy as well as intellectual property considerations.
: All relevant data are included in the article. The analyses were conducted based on publicly available information, which is presented and referenced in the article and its supplementary materials.
: Not applicable.
: Methodology: BS, LdJ. Formal analysis and investigation: BS, LdJ. Visualization: BS. Validation: LdJ. Writing – original draft preparation: BS. Writing – review and editing: LdJ, HPBLR, MP, CB. Supervision: MP, CB. Project administration: MW.
